Journal of the American Society of Nephrology · 2018 · 65 citations · 34 references
MedicineGeneticsMolecular GeneticsNeoplasiaRenal PathologyRenal PathophysiologyHereditary Kidney DiseasesHereditary Renal DiseasesRenal Cystic DiseasesRenal DiseaseRenal Tubular DisordersCkd ProgressionCystic EpitheliumExome SequencingHereditary Cystic Kidney DiseaseMutationRenal CystogenesisSomatic MutationsTubular Epithelial Cell Proliferation
Background Autosomal dominant polycystic kidney disease (ADPKD) is a ciliopathy caused by mutations in PKD1 and PKD2 that is characterized by renal tubular epithelial cell proliferation and progressive CKD. Although the molecular mechanisms involved in cystogenesis are not established, concurrent inactivating constitutional and somatic mutations in ADPKD genes in cyst epithelium have been proposed as a cellular recessive mechanism. Methods We characterized, by whole-exome sequencing (WES) and long-range PCR techniques, the somatic mutations in PKD1 and PKD2 genes in renal epithelial cells from 83 kidney cysts obtained from nine patients with ADPKD, for whom a constitutional mutation in PKD1 or PKD2 was identified. Results Complete sequencing data by long-range PCR and WES was available for 63 and 65 cysts, respectively. Private somatic mutations of PKD1 or PKD2 were identified in all patients and in 90% of the cysts analyzed; 90% of these mutations were truncating, splice site, or in-frame variations predicted to be pathogenic mutations. No trans -heterozygous mutations of PKD1 or PKD2 genes were identified. Copy number changes of PKD1 ranging from 151 bp to 28 kb were observed in 12% of the cysts. WES also identified significant mutations in 53 non- PKD1/2 genes, including other ciliopathy genes and cancer-related genes. Conclusions These findings support a cellular recessive mechanism for cyst formation in ADPKD caused primarily by inactivating constitutional and somatic mutations of PKD1 or PKD2 in kidney cyst epithelium. The potential interactions of these genes with other ciliopathy- and cancer-related genes to influence ADPKD severity merits further evaluation.
34
Signatures of mutational processes in human cancer
Ludmil B. Alexandrov, Serena Nik‐Zainal, David C. Wedge et al. · Nature · 2013 · 10.1K citations · Full text
Medicine, Cancer Biology, Oncology +14
A general framework for estimating the relative pathogenicity of human genetic variants
Martin Kircher, Daniela Witten, Preti Jain et al. · Nature Genetics · 2014 · 6.6K citations · Full text
Mutational heterogeneity in cancer and the search for new cancer-associated genes
Michael S. Lawrence, Petar Stojanov, Paz Polak et al. · Nature · 2013 · 5.7K citations · Full text
Feng Qian, Terry Watnick, Luiz F. Onuchic et al. · Cell · 1996 · 615 citations · Full text
Arlene B. Chapman, Olivier Devuyst, Kai‐Uwe Eckardt et al. · Kidney International · 2015 · 605 citations · Full text